Pharmaceutical products

Buyer: PHI University Clinic of Otrinolaringology


Share this: Share this page using Twitter Share this page using LinkedIn Share this page using Facebook Share this page using Google Share this page using email



Description:
Description:
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.
DRUGS AND SOLUTIONS.

Country:
Country:
Macedonia

Published:
Published date:
May 30 2017

Deadline:
Deadline:
Jun 16 2017

CPVs:
CPVs:
33600000 - Pharmaceutical products

Location:
Location:
Skopje

Email:
Email:
orlklinika@yahoo.com




OC ID:
Open Contracts ID:

Saved on:
Saved on:

Source ID:
Source ID:
204792-2017


Mail icon: Send an email to Open Opps Twitter logo: Open Opps Twitter page LinkedIn logo: Open Opps LinkedIn page Facebook logo: Open Opps Facebook page


Open Contracting Logo   Open Data Logo